Aomics Overview
- Year Founded
-
2015
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Aomics General Information
Description
Developer of a targeted cancer treatment designed for therapeutic use. The company combines an antibody with a chemotherapeutic molecule to direct the drug to cancer cells, enabling patients to receive a more selective treatment approach with the goal of reducing harm to healthy tissue.
Contact Information
Corporate Office
- 6076 Corte Del Cedro
- Carlsbad, CA 92011
- United States
Corporate Office
- 6076 Corte Del Cedro
- Carlsbad, CA 92011
- United States
Aomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 23-Oct-2015 | Completed | Startup |
Aomics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bio, Tech and Beyond | Accelerator/Incubator |
Aomics FAQs
-
When was Aomics founded?
Aomics was founded in 2015.
-
Where is Aomics headquartered?
Aomics is headquartered in Carlsbad, CA.
-
What industry is Aomics in?
Aomics’s primary industry is Drug Discovery.
-
Is Aomics a private or public company?
Aomics is a Private company.
-
What is Aomics’s current revenue?
The current revenue for Aomics is .
-
Who are Aomics’s investors?
Bio, Tech and Beyond has invested in Aomics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process